Loading…

Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I

Contrary to previous reports, recent enzymatic assays showed the predominance of chymase-like activity in rat arteries. We determined the existence and significance of such alternative pathways in rat carotid arteries by measuring contraction of arterial rings in organ baths and blood pressure in co...

Full description

Saved in:
Bibliographic Details
Published in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 1999-09, Vol.34 (3), p.525-530
Main Authors: Inoue, Kiyo, Nishimura, Hikaru, Kubota, Jiro, Kawamura, Keishiro
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4499-e1b2b73892acda8bce41b71a7d632abbe4677210a3aead719f4f7f1b6a8b59c23
cites cdi_FETCH-LOGICAL-c4499-e1b2b73892acda8bce41b71a7d632abbe4677210a3aead719f4f7f1b6a8b59c23
container_end_page 530
container_issue 3
container_start_page 525
container_title Hypertension (Dallas, Tex. 1979)
container_volume 34
creator Inoue, Kiyo
Nishimura, Hikaru
Kubota, Jiro
Kawamura, Keishiro
description Contrary to previous reports, recent enzymatic assays showed the predominance of chymase-like activity in rat arteries. We determined the existence and significance of such alternative pathways in rat carotid arteries by measuring contraction of arterial rings in organ baths and blood pressure in conscious rats. Hamster aorta served as a positive control for chymase. Temocapril (30 μmol/L) inhibited the contractions to angiotensin (Ang) I (10 to 10 mol/L) except at high concentrations of Ang I (>10 mol/L). Addition of chymostatin (100 μmol/L) to temocapril exerted a synergistic inhibitory effect. Hamster aorta gave similar results, except that temocapril was 30-fold less effective than in rat arteries. [Pro,D-Ala]Ang I (10 to 10 mol/L), a chymase-specific substrate, provoked similar responses in rat and hamster arteries; chymostatin, but not temocapril, attenuated the responses. CV 11974 (30 μmol/L), an Ang II type 1 receptor antagonist, abolished the responses to both peptides. In conscious rats, Ang I (0.03 to 30 μg/kg) and [Pro,D-Ala]Ang I (7 to 700 μg/kg) produced similar pressor responses. Not only CV 11974 (1 mg/kg) but also temocapril (2 mg/kg) abolished Ang I-induced responses in vivo. CV 11974, but not temocapril, inhibited responses to [Pro,D-Ala]Ang I. Our results showed the presence of the alternative pathway in rat arteries, but it did not play a major role. Arteries with the opposing characteristics of chymase responded equally to [Pro,D-Ala]Ang I. These findings suggest that biochemical and [Pro,D-Ala]Ang I-derived results may not reflect the functional significance of chymase.
doi_str_mv 10.1161/01.HYP.34.3.525
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70039832</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70039832</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4499-e1b2b73892acda8bce41b71a7d632abbe4677210a3aead719f4f7f1b6a8b59c23</originalsourceid><addsrcrecordid>eNpVkUFv1DAQhS0EokvhzA35gLgl9diTOD6uVi27UqVWqEVwshyv0w0kdrETqv33eNmVoCONRjPzzTu8IeQ9sBKghgsG5fr7bSmwFGXFqxdkARXHAqtavCQLBgoLBfDtjLxJ6QdjgIjyNTkDho1CVi3IuBwmF72Z-t-OLv1DHybnU-_pZkOvQhzzInia-y9mosuY2d4lemPtHHPxw57m-VcX93TdP-zoKnjr_BT_niUauueab8mrzgzJvTvVc3J_dXm3WhfXN583q-V1YRGVKhy0vJWiUdzYrWla6xBaCUZua8FN2zqspeTAjDDObCWoDjvZQVtntlKWi3Py6aj7GMOv2aVJj32ybhiMd2FOWjImVCMO4MURtDGkFF2nH2M_mrjXwPTBYc1AZ4e1QC10djhffDhJz-3otv_xR0sz8PEEmGTN0EXjbZ_-capBhgcMj9hTOHwg_RzmJxf1zplh2mmWA3ndFKCUYip3RU6uxB97l5Qk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70039832</pqid></control><display><type>article</type><title>Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I</title><source>EZB Electronic Journals Library</source><creator>Inoue, Kiyo ; Nishimura, Hikaru ; Kubota, Jiro ; Kawamura, Keishiro</creator><creatorcontrib>Inoue, Kiyo ; Nishimura, Hikaru ; Kubota, Jiro ; Kawamura, Keishiro</creatorcontrib><description>Contrary to previous reports, recent enzymatic assays showed the predominance of chymase-like activity in rat arteries. We determined the existence and significance of such alternative pathways in rat carotid arteries by measuring contraction of arterial rings in organ baths and blood pressure in conscious rats. Hamster aorta served as a positive control for chymase. Temocapril (30 μmol/L) inhibited the contractions to angiotensin (Ang) I (10 to 10 mol/L) except at high concentrations of Ang I (&gt;10 mol/L). Addition of chymostatin (100 μmol/L) to temocapril exerted a synergistic inhibitory effect. Hamster aorta gave similar results, except that temocapril was 30-fold less effective than in rat arteries. [Pro,D-Ala]Ang I (10 to 10 mol/L), a chymase-specific substrate, provoked similar responses in rat and hamster arteries; chymostatin, but not temocapril, attenuated the responses. CV 11974 (30 μmol/L), an Ang II type 1 receptor antagonist, abolished the responses to both peptides. In conscious rats, Ang I (0.03 to 30 μg/kg) and [Pro,D-Ala]Ang I (7 to 700 μg/kg) produced similar pressor responses. Not only CV 11974 (1 mg/kg) but also temocapril (2 mg/kg) abolished Ang I-induced responses in vivo. CV 11974, but not temocapril, inhibited responses to [Pro,D-Ala]Ang I. Our results showed the presence of the alternative pathway in rat arteries, but it did not play a major role. Arteries with the opposing characteristics of chymase responded equally to [Pro,D-Ala]Ang I. These findings suggest that biochemical and [Pro,D-Ala]Ang I-derived results may not reflect the functional significance of chymase.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/01.HYP.34.3.525</identifier><identifier>PMID: 10489405</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Angiotensin I - analogs &amp; derivatives ; Angiotensin I - metabolism ; Angiotensin I - pharmacology ; Angiotensin II - drug effects ; Angiotensin II - metabolism ; Angiotensin-Converting Enzyme Inhibitors - pharmacology ; Animals ; Antihypertensive Agents - pharmacology ; Aorta - drug effects ; Aorta - metabolism ; Arteries - drug effects ; Arteries - metabolism ; Benzimidazoles - pharmacology ; Biological and medical sciences ; Blood vessels and receptors ; Carotid Arteries - drug effects ; Carotid Arteries - metabolism ; Cricetinae ; Fundamental and applied biological sciences. Psychology ; Male ; Mesocricetus ; Pressoreceptors - drug effects ; Rats ; Rats, Inbred WKY ; Serine Proteinase Inhibitors - pharmacology ; Tetrazoles - pharmacology ; Time Factors ; Vasoconstriction - drug effects ; Vertebrates: cardiovascular system</subject><ispartof>Hypertension (Dallas, Tex. 1979), 1999-09, Vol.34 (3), p.525-530</ispartof><rights>1999 American Heart Association, Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4499-e1b2b73892acda8bce41b71a7d632abbe4677210a3aead719f4f7f1b6a8b59c23</citedby><cites>FETCH-LOGICAL-c4499-e1b2b73892acda8bce41b71a7d632abbe4677210a3aead719f4f7f1b6a8b59c23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1984045$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10489405$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Inoue, Kiyo</creatorcontrib><creatorcontrib>Nishimura, Hikaru</creatorcontrib><creatorcontrib>Kubota, Jiro</creatorcontrib><creatorcontrib>Kawamura, Keishiro</creatorcontrib><title>Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>Contrary to previous reports, recent enzymatic assays showed the predominance of chymase-like activity in rat arteries. We determined the existence and significance of such alternative pathways in rat carotid arteries by measuring contraction of arterial rings in organ baths and blood pressure in conscious rats. Hamster aorta served as a positive control for chymase. Temocapril (30 μmol/L) inhibited the contractions to angiotensin (Ang) I (10 to 10 mol/L) except at high concentrations of Ang I (&gt;10 mol/L). Addition of chymostatin (100 μmol/L) to temocapril exerted a synergistic inhibitory effect. Hamster aorta gave similar results, except that temocapril was 30-fold less effective than in rat arteries. [Pro,D-Ala]Ang I (10 to 10 mol/L), a chymase-specific substrate, provoked similar responses in rat and hamster arteries; chymostatin, but not temocapril, attenuated the responses. CV 11974 (30 μmol/L), an Ang II type 1 receptor antagonist, abolished the responses to both peptides. In conscious rats, Ang I (0.03 to 30 μg/kg) and [Pro,D-Ala]Ang I (7 to 700 μg/kg) produced similar pressor responses. Not only CV 11974 (1 mg/kg) but also temocapril (2 mg/kg) abolished Ang I-induced responses in vivo. CV 11974, but not temocapril, inhibited responses to [Pro,D-Ala]Ang I. Our results showed the presence of the alternative pathway in rat arteries, but it did not play a major role. Arteries with the opposing characteristics of chymase responded equally to [Pro,D-Ala]Ang I. These findings suggest that biochemical and [Pro,D-Ala]Ang I-derived results may not reflect the functional significance of chymase.</description><subject>Angiotensin I - analogs &amp; derivatives</subject><subject>Angiotensin I - metabolism</subject><subject>Angiotensin I - pharmacology</subject><subject>Angiotensin II - drug effects</subject><subject>Angiotensin II - metabolism</subject><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacology</subject><subject>Animals</subject><subject>Antihypertensive Agents - pharmacology</subject><subject>Aorta - drug effects</subject><subject>Aorta - metabolism</subject><subject>Arteries - drug effects</subject><subject>Arteries - metabolism</subject><subject>Benzimidazoles - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Blood vessels and receptors</subject><subject>Carotid Arteries - drug effects</subject><subject>Carotid Arteries - metabolism</subject><subject>Cricetinae</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Male</subject><subject>Mesocricetus</subject><subject>Pressoreceptors - drug effects</subject><subject>Rats</subject><subject>Rats, Inbred WKY</subject><subject>Serine Proteinase Inhibitors - pharmacology</subject><subject>Tetrazoles - pharmacology</subject><subject>Time Factors</subject><subject>Vasoconstriction - drug effects</subject><subject>Vertebrates: cardiovascular system</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNpVkUFv1DAQhS0EokvhzA35gLgl9diTOD6uVi27UqVWqEVwshyv0w0kdrETqv33eNmVoCONRjPzzTu8IeQ9sBKghgsG5fr7bSmwFGXFqxdkARXHAqtavCQLBgoLBfDtjLxJ6QdjgIjyNTkDho1CVi3IuBwmF72Z-t-OLv1DHybnU-_pZkOvQhzzInia-y9mosuY2d4lemPtHHPxw57m-VcX93TdP-zoKnjr_BT_niUauueab8mrzgzJvTvVc3J_dXm3WhfXN583q-V1YRGVKhy0vJWiUdzYrWla6xBaCUZua8FN2zqspeTAjDDObCWoDjvZQVtntlKWi3Py6aj7GMOv2aVJj32ybhiMd2FOWjImVCMO4MURtDGkFF2nH2M_mrjXwPTBYc1AZ4e1QC10djhffDhJz-3otv_xR0sz8PEEmGTN0EXjbZ_-capBhgcMj9hTOHwg_RzmJxf1zplh2mmWA3ndFKCUYip3RU6uxB97l5Qk</recordid><startdate>199909</startdate><enddate>199909</enddate><creator>Inoue, Kiyo</creator><creator>Nishimura, Hikaru</creator><creator>Kubota, Jiro</creator><creator>Kawamura, Keishiro</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199909</creationdate><title>Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I</title><author>Inoue, Kiyo ; Nishimura, Hikaru ; Kubota, Jiro ; Kawamura, Keishiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4499-e1b2b73892acda8bce41b71a7d632abbe4677210a3aead719f4f7f1b6a8b59c23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Angiotensin I - analogs &amp; derivatives</topic><topic>Angiotensin I - metabolism</topic><topic>Angiotensin I - pharmacology</topic><topic>Angiotensin II - drug effects</topic><topic>Angiotensin II - metabolism</topic><topic>Angiotensin-Converting Enzyme Inhibitors - pharmacology</topic><topic>Animals</topic><topic>Antihypertensive Agents - pharmacology</topic><topic>Aorta - drug effects</topic><topic>Aorta - metabolism</topic><topic>Arteries - drug effects</topic><topic>Arteries - metabolism</topic><topic>Benzimidazoles - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Blood vessels and receptors</topic><topic>Carotid Arteries - drug effects</topic><topic>Carotid Arteries - metabolism</topic><topic>Cricetinae</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Male</topic><topic>Mesocricetus</topic><topic>Pressoreceptors - drug effects</topic><topic>Rats</topic><topic>Rats, Inbred WKY</topic><topic>Serine Proteinase Inhibitors - pharmacology</topic><topic>Tetrazoles - pharmacology</topic><topic>Time Factors</topic><topic>Vasoconstriction - drug effects</topic><topic>Vertebrates: cardiovascular system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Inoue, Kiyo</creatorcontrib><creatorcontrib>Nishimura, Hikaru</creatorcontrib><creatorcontrib>Kubota, Jiro</creatorcontrib><creatorcontrib>Kawamura, Keishiro</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Inoue, Kiyo</au><au>Nishimura, Hikaru</au><au>Kubota, Jiro</au><au>Kawamura, Keishiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>1999-09</date><risdate>1999</risdate><volume>34</volume><issue>3</issue><spage>525</spage><epage>530</epage><pages>525-530</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>Contrary to previous reports, recent enzymatic assays showed the predominance of chymase-like activity in rat arteries. We determined the existence and significance of such alternative pathways in rat carotid arteries by measuring contraction of arterial rings in organ baths and blood pressure in conscious rats. Hamster aorta served as a positive control for chymase. Temocapril (30 μmol/L) inhibited the contractions to angiotensin (Ang) I (10 to 10 mol/L) except at high concentrations of Ang I (&gt;10 mol/L). Addition of chymostatin (100 μmol/L) to temocapril exerted a synergistic inhibitory effect. Hamster aorta gave similar results, except that temocapril was 30-fold less effective than in rat arteries. [Pro,D-Ala]Ang I (10 to 10 mol/L), a chymase-specific substrate, provoked similar responses in rat and hamster arteries; chymostatin, but not temocapril, attenuated the responses. CV 11974 (30 μmol/L), an Ang II type 1 receptor antagonist, abolished the responses to both peptides. In conscious rats, Ang I (0.03 to 30 μg/kg) and [Pro,D-Ala]Ang I (7 to 700 μg/kg) produced similar pressor responses. Not only CV 11974 (1 mg/kg) but also temocapril (2 mg/kg) abolished Ang I-induced responses in vivo. CV 11974, but not temocapril, inhibited responses to [Pro,D-Ala]Ang I. Our results showed the presence of the alternative pathway in rat arteries, but it did not play a major role. Arteries with the opposing characteristics of chymase responded equally to [Pro,D-Ala]Ang I. These findings suggest that biochemical and [Pro,D-Ala]Ang I-derived results may not reflect the functional significance of chymase.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>10489405</pmid><doi>10.1161/01.HYP.34.3.525</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0194-911X
ispartof Hypertension (Dallas, Tex. 1979), 1999-09, Vol.34 (3), p.525-530
issn 0194-911X
1524-4563
language eng
recordid cdi_proquest_miscellaneous_70039832
source EZB Electronic Journals Library
subjects Angiotensin I - analogs & derivatives
Angiotensin I - metabolism
Angiotensin I - pharmacology
Angiotensin II - drug effects
Angiotensin II - metabolism
Angiotensin-Converting Enzyme Inhibitors - pharmacology
Animals
Antihypertensive Agents - pharmacology
Aorta - drug effects
Aorta - metabolism
Arteries - drug effects
Arteries - metabolism
Benzimidazoles - pharmacology
Biological and medical sciences
Blood vessels and receptors
Carotid Arteries - drug effects
Carotid Arteries - metabolism
Cricetinae
Fundamental and applied biological sciences. Psychology
Male
Mesocricetus
Pressoreceptors - drug effects
Rats
Rats, Inbred WKY
Serine Proteinase Inhibitors - pharmacology
Tetrazoles - pharmacology
Time Factors
Vasoconstriction - drug effects
Vertebrates: cardiovascular system
title Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T01%3A00%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alternative%20Angiotensin%20II%20Formation%20in%20Rat%20Arteries%20Occurs%20Only%20at%20Very%20High%20Concentrations%20of%20Angiotensin%20I&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Inoue,%20Kiyo&rft.date=1999-09&rft.volume=34&rft.issue=3&rft.spage=525&rft.epage=530&rft.pages=525-530&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/01.HYP.34.3.525&rft_dat=%3Cproquest_cross%3E70039832%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4499-e1b2b73892acda8bce41b71a7d632abbe4677210a3aead719f4f7f1b6a8b59c23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70039832&rft_id=info:pmid/10489405&rfr_iscdi=true